Axogen, Inc. (LON:0HKD)
London · Delayed Price · Currency is GBP · Price in USD 16.31
-0.37 (-2.22%)
At close: Sep 15, 2025
Axogen Market Cap
Axogen has a market cap or net worth of 566.49 million as of September 18, 2025. Its market cap has increased by 29.16% in one year.
Market Cap
566.49M
Enterprise Value
596.02M
Revenue
148.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.31
Market Cap Chart
Since October 3, 2011, Axogen's market cap has increased from 7.54M to 566.49M, an increase of 7,408.93%. That is a compound annual growth rate of 36.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 566.49M | -2.21% |
| Dec 31, 2024 | 579.31M | 151.00% |
| Dec 29, 2023 | 230.80M | -34.10% |
| Dec 30, 2022 | 350.26M | 21.78% |
| Dec 31, 2021 | 287.61M | -45.33% |
| Dec 31, 2020 | 526.08M | -1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.94B |
| GSK plc | 58.89B |
| Haleon | 30.40B |
| Smith & Nephew | 11.94B |
| ConvaTec Group | 4.69B |
| Hikma Pharmaceuticals | 3.58B |
| HUTCHMED (China) | 2.12B |
| Genus | 1.65B |